STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class
STAT News · LC · trust 36/100
The FDA approved a treatment for advanced multiple myeloma made by Bristol Myers Squibb, marking the debut of a new class of drugs for the blood cancer.
Read the original at STAT News →
Open in TruthVane →